Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NATHBIOGEN Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low but stable ROE
Neutral
Moderate and stable operating margin
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
Moderate dividend yield
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.232703.
Snapshot
See detailed analysis
NATHBIOGEN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NATHBIOGEN Bulk, Block & Insider Trades
NATHBIOGEN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aura... Read More
Key personnel
Mr. Amol Gupta
Chief Financial Officer
Mr. Dhiraj Rajesh Rathi
Compliance Officer, Company Secretary
Mr. Satish KagliwalD
Managing Director, Director
Mrs. Jeevanlata Nandkishor KagliwalD
Additional Director
Mrs. Sweta Garodia KagliwalD
Non-Executive Director
Mr. Madhukar DeshpandeD
Additional Independent Director
Mr. Vadla NagabhushanamD
Additional Independent Director
Mr. Hitesh Rajnikant PurohitD
Additional Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Nath Bio-Genes (India) Ltd.?
The current share price of Nath Bio-Genes (India) Ltd. is ₹ 151.14 as of 09 Jan 2026.
What is the PE ratio of Nath Bio-Genes (India) Ltd.?
The Price-to-Earnings (PE) ratio of Nath Bio-Genes (India) Ltd. is 6.21 as of the latest financial data.
What is the ROE and ROCE of Nath Bio-Genes (India) Ltd.?
Nath Bio-Genes (India) Ltd. has a Return on Equity (ROE) of 7.00% and a Return on Capital Employed (ROCE) of 5.94% as per the latest financial reports.
What is the market cap of Nath Bio-Genes (India) Ltd.?
The market capitalization of Nath Bio-Genes (India) Ltd. stands at ₹ 287.23 Cr.
What is the dividend yield of Nath Bio-Genes (India) Ltd.?
The dividend yield of Nath Bio-Genes (India) Ltd. is 1.32% based on the current market price.
What is the RSI of Nath Bio-Genes (India) Ltd.?
The Relative Strength Index (RSI) of Nath Bio-Genes (India) Ltd. is 43.45.
What is the FII and DII holding in Nath Bio-Genes (India) Ltd.?
Foreign Institutional Investors (FII) hold 0.32% and Domestic Institutional Investors (DII) hold 0.76% of Nath Bio-Genes (India) Ltd. shares.
What sector does Nath Bio-Genes (India) Ltd. belong to?
Nath Bio-Genes (India) Ltd. operates in the Fast Moving Consumer Goods sector.
What is the beta of Nath Bio-Genes (India) Ltd. stock?
The beta of Nath Bio-Genes (India) Ltd. stock is 1.01, indicating its volatility relative to the broader market.
